Demographics and Risk Factors of Pediatric Pulmonary Hypertension Readmissions

Mukul Sehgal1, Amod Amritphale2, Shashank Vadayla3

  • 1Pediatric Critical Care, University of South Alabama College of Medicine, Mobile, USA.

Cureus
|December 2, 2021
PubMed

Insights

Pediatric pulmonary hypertension (PH) patients have higher 30-day readmission rates. Invasive ventilation, higher illness severity, and female gender increase readmission risk in these children.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Health Services Research

Background:

  • Pediatric pulmonary hypertension (PH) is a serious condition associated with significant morbidity and mortality.
  • PH contributes to increased hospital readmission rates among pediatric patients.
  • Identifying risk factors for readmission is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate risk factors and comorbidities associated with 30-day readmissions in pediatric PH patients.
  • To compare readmission rates in pediatric PH patients to other pediatric diagnoses.

Main Methods:

  • Utilized the National Readmission Database (NRD) for 2017.
  • Included pediatric patients (<18 years) diagnosed with PH (ICD-10 codes).
  • Performed statistical analysis using SPSS v25.0.

Main Results:

  • The 30-day readmission rate for pediatric PH was 14.43%, significantly higher than other pediatric diagnoses (OR 4.02).
  • Invasive mechanical ventilation (endotracheal tube or tracheostomy) and higher All Patients Refined Diagnosis Related Groups (APR-DRG) scores were linked to increased readmissions.
  • Sepsis and respiratory infections were associated with lower readmission rates.

Conclusions:

  • Pediatric PH is linked to elevated 30-day readmission rates.
  • Factors such as invasive mechanical ventilation, Medicaid insurance, higher illness severity, and female gender predict higher readmission likelihood.
  • The study identified key predictors for readmission, informing targeted interventions for high-risk pediatric PH patients.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
319
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
19
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
20
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
387
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
72